HALIMI, Jean-Michel, Pantelis SARAFIDIS, Michel AZIZI, Grzegorz BILO, Thilo BURKARD, Michael BURSZTYN, Miguel CAMAFORT, Neil CHAPMAN, Santina COTTONE, de Backer TINE, Jaap DEINUM, Philippe DELMOTTE, Maria DOROBANTU, Michalis DOUMAS, Rainer DUSING, Beatrice DULY-BOUHANICK, Jean-Pierre FAUVEL, Pierre FESLER, Zbigniew GACIONG, Eugenia GKALIAGKOUSI, Daniel GORDIN, Guido GRASSI, Charalampos GRASSOS, Dominique GUERROT, Justine HUART, Raffaele IZZO, Fernando Jaen AGUILA, Zoltan JARAI, Thomas KAHAN, Ilkka KANTOLA, Eva KOCIANOVA, Florian P LIMBOURG, Marilucy LOPEZ-SUBLET, Francesca MALLAMACI, Athanasios MANOLIS, Maria MARKETOU, Gert MAYER, Alberto MAZZA, Iain M MACINTYRE, Jean-Jacques MOURAD, Maria Lorenza MUIESAN, Edgar NASR, Peter NILSSON, Anna OLIVERAS, Olivier ORMEZZANO, Vitor PAIXAO-DIAS, Ioannis PAPADAKIS, Dimitris PAPADOPOULOS, Sabine PERL, Jorge POLONIA, Roberto PONTREMOLI, Giacomo PUCCI, Nicolas Roberto ROBLES, Sebastien RUBIN, Luis Miguel RUILOPE, Lars Christian RUMP, Sahrai SAEED, Elias SANIDAS, Riccardo SARZANI, Roland SCHMIEDER, Francois SILHOL, Sekib SOKOLOVIC, Marit SOLBU, Miroslav SOUČEK, George STERGIOU, Isabella SUDANO, Ramzi TABBALAT, Istemihan TENGIZ, Helen TRIANTAFYLLIDI, Konstontinos TSIOUFIS, Jan VACLAVIK, van der Giet MARKUS, Van der Niepen PATRICIA, Franco VEGLIO, Reto M VENZIN, Margus VIIGIMAA, Thomas WEBER, Jiri WIDIMSKY, Gregoire WUERZNER, Parounak ZELVEIAN, Pantelis ZEBEKAKIS, Stephan LUEDERS, Alexandre PERSU, Reinhold KREUTZ and Liffert VOGT. Screening and management of hypertensive patients with chronic kidney disease referred to Hypertension Excellence Centres among 27 countries. A pilot survey based on questionnaire. Journal of Hypertension. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS, 2024, vol. 42, No 9, p. 1544-1554. ISSN 0263-6352. Available from: https://dx.doi.org/10.1097/HJH.0000000000003756.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Screening and management of hypertensive patients with chronic kidney disease referred to Hypertension Excellence Centres among 27 countries. A pilot survey based on questionnaire
Authors HALIMI, Jean-Michel, Pantelis SARAFIDIS, Michel AZIZI, Grzegorz BILO, Thilo BURKARD, Michael BURSZTYN, Miguel CAMAFORT, Neil CHAPMAN, Santina COTTONE, de Backer TINE, Jaap DEINUM, Philippe DELMOTTE, Maria DOROBANTU, Michalis DOUMAS, Rainer DUSING, Beatrice DULY-BOUHANICK, Jean-Pierre FAUVEL, Pierre FESLER, Zbigniew GACIONG, Eugenia GKALIAGKOUSI, Daniel GORDIN, Guido GRASSI, Charalampos GRASSOS, Dominique GUERROT, Justine HUART, Raffaele IZZO, Fernando Jaen AGUILA, Zoltan JARAI, Thomas KAHAN, Ilkka KANTOLA, Eva KOCIANOVA, Florian P LIMBOURG, Marilucy LOPEZ-SUBLET, Francesca MALLAMACI, Athanasios MANOLIS, Maria MARKETOU, Gert MAYER, Alberto MAZZA, Iain M MACINTYRE, Jean-Jacques MOURAD, Maria Lorenza MUIESAN, Edgar NASR, Peter NILSSON, Anna OLIVERAS, Olivier ORMEZZANO, Vitor PAIXAO-DIAS, Ioannis PAPADAKIS, Dimitris PAPADOPOULOS, Sabine PERL, Jorge POLONIA, Roberto PONTREMOLI, Giacomo PUCCI, Nicolas Roberto ROBLES, Sebastien RUBIN, Luis Miguel RUILOPE, Lars Christian RUMP, Sahrai SAEED, Elias SANIDAS, Riccardo SARZANI, Roland SCHMIEDER, Francois SILHOL, Sekib SOKOLOVIC, Marit SOLBU, Miroslav SOUČEK (203 Czech Republic, belonging to the institution), George STERGIOU, Isabella SUDANO, Ramzi TABBALAT, Istemihan TENGIZ, Helen TRIANTAFYLLIDI, Konstontinos TSIOUFIS, Jan VACLAVIK, van der Giet MARKUS, Van der Niepen PATRICIA, Franco VEGLIO, Reto M VENZIN, Margus VIIGIMAA, Thomas WEBER, Jiri WIDIMSKY, Gregoire WUERZNER, Parounak ZELVEIAN, Pantelis ZEBEKAKIS, Stephan LUEDERS, Alexandre PERSU, Reinhold KREUTZ and Liffert VOGT.
Edition Journal of Hypertension, PHILADELPHIA, LIPPINCOTT WILLIAMS & WILKINS, 2024, 0263-6352.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30201 Cardiac and Cardiovascular systems
Country of publisher United States of America
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 4.900 in 2022
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.1097/HJH.0000000000003756
UT WoS 001290622400001
Keywords in English albuminuria; chronic kidney disease; glomerular filtration rate; hypertension; management; screening
Tags 14110116, rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Tereza Miškechová, učo 341652. Changed: 6/9/2024 07:50.
Abstract
Objective: Real-life management of hypertensive patients with chronic kidney disease (CKD) is unclear. Methods: A survey was conducted in 2023 by the European Society of Hypertension (ESH) to assess management of CKD patients referred to ESH-Hypertension Excellence Centres (ESH-ECs) at first referral visit. The questionnaire contained 64 questions with which ESH-ECs representatives were asked to estimate preexisting CKD management quality. Results: Overall, 88 ESH-ECs from 27 countries participated (fully completed surveys: 66/88 [75.0%]). ESH-ECs reported that 28% (median, interquartile range: 1550%) had preexisting CKD, with 10% of them (5- 30%) previously referred to a nephrologist, while 30% (15-40%) had resistant hypertension. The reported rate of previous recent (<6 months) estimated glomerular filtration rate (eGFR) and urine albumin- creatinine ratio (UACR) testing were 80% (50- 95%) and 30% (15- 50%), respectively. The reported use of renin-angiotensin system blockers was 80% (70-90%). When a nephrologist was part of the ESH-EC teams the reported rates SGLT2 inhibitors (27.5% [20- 40%] vs. 15% [10-25], P = 0.003), GLP1-RA (10% [10- 20%] vs. 5% [5- 10%], P = 0.003) and mineralocorticoid receptor antagonists (20% [1030%] vs. 15% [10- 20%], P = 0.05) use were greater as compared to ESH-ECs without nephrologist participation. The rate of reported resistant hypertension, recent eGFR and UACR results and management of CKD patients prior to referral varied widely across countries. Conclusions: Our estimation indicates deficits regarding CKD screening, use of nephroprotective drugs and referral to nephrologists before referral to ESH-ECs but results varied widely across countries. This information can be used to build specific programs to improve care in hypertensives with CKD.
PrintDisplayed: 9/9/2024 06:12